nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—RET—autonomic nervous system—allergic rhinitis	0.0123	0.0368	CbGeAlD
Ruxolitinib—GRK7—eye—allergic rhinitis	0.0104	0.0312	CbGeAlD
Ruxolitinib—CYP3A4—Flunisolide—allergic rhinitis	0.00895	0.192	CbGbCtD
Ruxolitinib—CYP3A4—Olopatadine—allergic rhinitis	0.00842	0.18	CbGbCtD
Ruxolitinib—Tuberculosis—Betamethasone—allergic rhinitis	0.00838	0.0335	CcSEcCtD
Ruxolitinib—Tuberculosis—Dexamethasone—allergic rhinitis	0.00838	0.0335	CcSEcCtD
Ruxolitinib—PLK1—respiratory system—allergic rhinitis	0.00773	0.0232	CbGeAlD
Ruxolitinib—GRK1—eye—allergic rhinitis	0.00752	0.0226	CbGeAlD
Ruxolitinib—PLK1—skin of body—allergic rhinitis	0.00615	0.0185	CbGeAlD
Ruxolitinib—PLK1—Thiothixene—Olopatadine—allergic rhinitis	0.00533	1	CbGdCrCtD
Ruxolitinib—PLK3—bronchus—allergic rhinitis	0.00531	0.016	CbGeAlD
Ruxolitinib—CYP3A4—Loratadine—allergic rhinitis	0.00514	0.11	CbGbCtD
Ruxolitinib—CYP3A4—Montelukast—allergic rhinitis	0.00514	0.11	CbGbCtD
Ruxolitinib—JAK1—respiratory system—allergic rhinitis	0.00495	0.0149	CbGeAlD
Ruxolitinib—PLK4—respiratory system—allergic rhinitis	0.00492	0.0148	CbGeAlD
Ruxolitinib—CAMK1D—respiratory system—allergic rhinitis	0.00483	0.0145	CbGeAlD
Ruxolitinib—PLK3—trachea—allergic rhinitis	0.00477	0.0143	CbGeAlD
Ruxolitinib—CYP3A4—Methylprednisolone—allergic rhinitis	0.0047	0.101	CbGbCtD
Ruxolitinib—HIPK2—respiratory system—allergic rhinitis	0.00462	0.0139	CbGeAlD
Ruxolitinib—PRKG2—lung—allergic rhinitis	0.00458	0.0137	CbGeAlD
Ruxolitinib—MAP3K19—respiratory system—allergic rhinitis	0.00453	0.0136	CbGeAlD
Ruxolitinib—CAMK1D—eye—allergic rhinitis	0.00442	0.0133	CbGeAlD
Ruxolitinib—CLK2—respiratory system—allergic rhinitis	0.0044	0.0132	CbGeAlD
Ruxolitinib—PRKCE—lung—allergic rhinitis	0.00427	0.0128	CbGeAlD
Ruxolitinib—ROCK1—respiratory system—allergic rhinitis	0.00426	0.0128	CbGeAlD
Ruxolitinib—DYRK1A—respiratory system—allergic rhinitis	0.00416	0.0125	CbGeAlD
Ruxolitinib—BMPR2—respiratory system—allergic rhinitis	0.00414	0.0124	CbGeAlD
Ruxolitinib—JAK1—epithelium—allergic rhinitis	0.00414	0.0124	CbGeAlD
Ruxolitinib—RPS6KA6—lung—allergic rhinitis	0.00411	0.0123	CbGeAlD
Ruxolitinib—PLK1—lung—allergic rhinitis	0.00411	0.0123	CbGeAlD
Ruxolitinib—JAK1—bronchus—allergic rhinitis	0.00408	0.0122	CbGeAlD
Ruxolitinib—CAMK1D—bronchus—allergic rhinitis	0.00398	0.0119	CbGeAlD
Ruxolitinib—JAK1—skin of body—allergic rhinitis	0.00394	0.0118	CbGeAlD
Ruxolitinib—ROCK1—eye—allergic rhinitis	0.0039	0.0117	CbGeAlD
Ruxolitinib—DAPK2—bronchus—allergic rhinitis	0.00389	0.0117	CbGeAlD
Ruxolitinib—Weight increased—Cyproheptadine—allergic rhinitis	0.00383	0.0153	CcSEcCtD
Ruxolitinib—Contusion—Montelukast—allergic rhinitis	0.0038	0.0152	CcSEcCtD
Ruxolitinib—CAMK2G—respiratory system—allergic rhinitis	0.00371	0.0111	CbGeAlD
Ruxolitinib—LRRK2—respiratory system—allergic rhinitis	0.00367	0.011	CbGeAlD
Ruxolitinib—JAK1—trachea—allergic rhinitis	0.00366	0.011	CbGeAlD
Ruxolitinib—DCLK1—trachea—allergic rhinitis	0.00366	0.011	CbGeAlD
Ruxolitinib—DAPK3—bronchus—allergic rhinitis	0.00366	0.011	CbGeAlD
Ruxolitinib—Infestation NOS—Desloratadine—allergic rhinitis	0.00365	0.0146	CcSEcCtD
Ruxolitinib—Infestation—Desloratadine—allergic rhinitis	0.00365	0.0146	CcSEcCtD
Ruxolitinib—CLK2—bronchus—allergic rhinitis	0.00362	0.0109	CbGeAlD
Ruxolitinib—CAMK1D—trachea—allergic rhinitis	0.00357	0.0107	CbGeAlD
Ruxolitinib—ROCK1—epithelium—allergic rhinitis	0.00356	0.0107	CbGeAlD
Ruxolitinib—CYP3A4—Triamcinolone—allergic rhinitis	0.00356	0.0764	CbGbCtD
Ruxolitinib—Urinary tract infection—Desloratadine—allergic rhinitis	0.00355	0.0142	CcSEcCtD
Ruxolitinib—DAPK2—trachea—allergic rhinitis	0.00349	0.0105	CbGeAlD
Ruxolitinib—Hepatobiliary disease—Desloratadine—allergic rhinitis	0.00345	0.0138	CcSEcCtD
Ruxolitinib—Epistaxis—Desloratadine—allergic rhinitis	0.00344	0.0138	CcSEcCtD
Ruxolitinib—PLK3—lung—allergic rhinitis	0.00343	0.0103	CbGeAlD
Ruxolitinib—BMPR2—bronchus—allergic rhinitis	0.00341	0.0102	CbGeAlD
Ruxolitinib—CAMK2G—eye—allergic rhinitis	0.00339	0.0102	CbGeAlD
Ruxolitinib—LTK—lung—allergic rhinitis	0.00331	0.00994	CbGeAlD
Ruxolitinib—BMPR2—skin of body—allergic rhinitis	0.00329	0.00989	CbGeAlD
Ruxolitinib—TYK2—respiratory system—allergic rhinitis	0.00327	0.00983	CbGeAlD
Ruxolitinib—CLK2—trachea—allergic rhinitis	0.00325	0.00977	CbGeAlD
Ruxolitinib—MKNK2—respiratory system—allergic rhinitis	0.00323	0.00971	CbGeAlD
Ruxolitinib—CAMK1—lung—allergic rhinitis	0.00321	0.00963	CbGeAlD
Ruxolitinib—Weight increased—Olopatadine—allergic rhinitis	0.00319	0.0127	CcSEcCtD
Ruxolitinib—Infestation NOS—Olopatadine—allergic rhinitis	0.00312	0.0125	CcSEcCtD
Ruxolitinib—Infestation—Olopatadine—allergic rhinitis	0.00312	0.0125	CcSEcCtD
Ruxolitinib—MARK2—lung—allergic rhinitis	0.00311	0.00935	CbGeAlD
Ruxolitinib—CYP3A4—Betamethasone—allergic rhinitis	0.00306	0.0656	CbGbCtD
Ruxolitinib—BMP2K—bronchus—allergic rhinitis	0.00305	0.00916	CbGeAlD
Ruxolitinib—Urinary tract infection—Olopatadine—allergic rhinitis	0.00303	0.0121	CcSEcCtD
Ruxolitinib—CYP3A4—Prednisolone—allergic rhinitis	0.00302	0.0647	CbGbCtD
Ruxolitinib—TYK2—eye—allergic rhinitis	0.00299	0.00898	CbGeAlD
Ruxolitinib—JAK2—respiratory system—allergic rhinitis	0.00298	0.00895	CbGeAlD
Ruxolitinib—MKNK2—eye—allergic rhinitis	0.00295	0.00887	CbGeAlD
Ruxolitinib—Epistaxis—Olopatadine—allergic rhinitis	0.00294	0.0118	CcSEcCtD
Ruxolitinib—NUAK2—trachea—allergic rhinitis	0.00293	0.00879	CbGeAlD
Ruxolitinib—TAOK2—lung—allergic rhinitis	0.00288	0.00865	CbGeAlD
Ruxolitinib—CYP3A4—Hydrocortisone—allergic rhinitis	0.00286	0.0613	CbGbCtD
Ruxolitinib—MAP3K7—bronchus—allergic rhinitis	0.00274	0.00824	CbGeAlD
Ruxolitinib—MKNK2—epithelium—allergic rhinitis	0.0027	0.00811	CbGeAlD
Ruxolitinib—TYK2—bronchus—allergic rhinitis	0.0027	0.00809	CbGeAlD
Ruxolitinib—IRAK1—bronchus—allergic rhinitis	0.00266	0.00799	CbGeAlD
Ruxolitinib—MKNK2—bronchus—allergic rhinitis	0.00266	0.00799	CbGeAlD
Ruxolitinib—JAK3—lung—allergic rhinitis	0.00265	0.00795	CbGeAlD
Ruxolitinib—RET—epithelium—allergic rhinitis	0.00263	0.00791	CbGeAlD
Ruxolitinib—JAK1—lung—allergic rhinitis	0.00263	0.0079	CbGeAlD
Ruxolitinib—DCLK1—lung—allergic rhinitis	0.00263	0.0079	CbGeAlD
Ruxolitinib—TAOK3—respiratory system—allergic rhinitis	0.00262	0.00786	CbGeAlD
Ruxolitinib—PLK4—lung—allergic rhinitis	0.00261	0.00785	CbGeAlD
Ruxolitinib—TYK2—skin of body—allergic rhinitis	0.0026	0.00782	CbGeAlD
Ruxolitinib—CAMK1D—lung—allergic rhinitis	0.00257	0.00771	CbGeAlD
Ruxolitinib—PHKG2—lung—allergic rhinitis	0.00255	0.00766	CbGeAlD
Ruxolitinib—DAPK2—lung—allergic rhinitis	0.00251	0.00753	CbGeAlD
Ruxolitinib—JAK2—epithelium—allergic rhinitis	0.00249	0.00748	CbGeAlD
Ruxolitinib—STK16—lung—allergic rhinitis	0.00247	0.00741	CbGeAlD
Ruxolitinib—MAP3K7—trachea—allergic rhinitis	0.00246	0.0074	CbGeAlD
Ruxolitinib—HIPK2—lung—allergic rhinitis	0.00245	0.00737	CbGeAlD
Ruxolitinib—JAK2—bronchus—allergic rhinitis	0.00245	0.00736	CbGeAlD
Ruxolitinib—TYK2—trachea—allergic rhinitis	0.00242	0.00727	CbGeAlD
Ruxolitinib—MAP3K19—lung—allergic rhinitis	0.00241	0.00722	CbGeAlD
Ruxolitinib—TAOK3—eye—allergic rhinitis	0.00239	0.00718	CbGeAlD
Ruxolitinib—MKNK2—trachea—allergic rhinitis	0.00239	0.00717	CbGeAlD
Ruxolitinib—JAK2—skin of body—allergic rhinitis	0.00237	0.00711	CbGeAlD
Ruxolitinib—MAP3K3—bronchus—allergic rhinitis	0.00236	0.0071	CbGeAlD
Ruxolitinib—DAPK3—lung—allergic rhinitis	0.00236	0.00708	CbGeAlD
Ruxolitinib—Thrombocytopenia—Cyproheptadine—allergic rhinitis	0.00234	0.00937	CcSEcCtD
Ruxolitinib—CLK2—lung—allergic rhinitis	0.00234	0.00702	CbGeAlD
Ruxolitinib—Infection—Desloratadine—allergic rhinitis	0.00231	0.00924	CcSEcCtD
Ruxolitinib—Nervous system disorder—Desloratadine—allergic rhinitis	0.00228	0.00912	CcSEcCtD
Ruxolitinib—MAP3K3—skin of body—allergic rhinitis	0.00228	0.00685	CbGeAlD
Ruxolitinib—ROCK1—lung—allergic rhinitis	0.00226	0.0068	CbGeAlD
Ruxolitinib—Weight increased—Cetirizine—allergic rhinitis	0.00226	0.00903	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Loratadine—allergic rhinitis	0.00222	0.00889	CcSEcCtD
Ruxolitinib—Weight increased—Flunisolide—allergic rhinitis	0.00222	0.00887	CcSEcCtD
Ruxolitinib—Epistaxis—Loratadine—allergic rhinitis	0.00222	0.00886	CcSEcCtD
Ruxolitinib—DYRK1A—lung—allergic rhinitis	0.00221	0.00663	CbGeAlD
Ruxolitinib—JAK2—trachea—allergic rhinitis	0.0022	0.00661	CbGeAlD
Ruxolitinib—BMPR2—lung—allergic rhinitis	0.0022	0.00661	CbGeAlD
Ruxolitinib—TAOK3—bronchus—allergic rhinitis	0.00215	0.00647	CbGeAlD
Ruxolitinib—Urinary tract infection—Cetirizine—allergic rhinitis	0.00215	0.00859	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Montelukast—allergic rhinitis	0.00212	0.00849	CcSEcCtD
Ruxolitinib—MAP3K3—trachea—allergic rhinitis	0.00212	0.00637	CbGeAlD
Ruxolitinib—Urinary tract infection—Flunisolide—allergic rhinitis	0.00212	0.00845	CcSEcCtD
Ruxolitinib—Haematuria—Cetirizine—allergic rhinitis	0.00211	0.00843	CcSEcCtD
Ruxolitinib—NUAK2—lung—allergic rhinitis	0.0021	0.00631	CbGeAlD
Ruxolitinib—Epistaxis—Cetirizine—allergic rhinitis	0.00209	0.00834	CcSEcCtD
Ruxolitinib—Fatigue—Cyproheptadine—allergic rhinitis	0.00206	0.00825	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Olopatadine—allergic rhinitis	0.00206	0.00824	CcSEcCtD
Ruxolitinib—Contusion—Hydrocortisone—allergic rhinitis	0.00205	0.0082	CcSEcCtD
Ruxolitinib—Epistaxis—Flunisolide—allergic rhinitis	0.00205	0.0082	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Desloratadine—allergic rhinitis	0.00201	0.00803	CcSEcCtD
Ruxolitinib—Fatigue—Desloratadine—allergic rhinitis	0.00201	0.00802	CcSEcCtD
Ruxolitinib—Infection—Olopatadine—allergic rhinitis	0.00198	0.0079	CcSEcCtD
Ruxolitinib—CAMK2G—lung—allergic rhinitis	0.00197	0.00591	CbGeAlD
Ruxolitinib—BMP2K—lung—allergic rhinitis	0.00197	0.00591	CbGeAlD
Ruxolitinib—Nervous system disorder—Olopatadine—allergic rhinitis	0.00195	0.0078	CcSEcCtD
Ruxolitinib—LRRK2—lung—allergic rhinitis	0.00195	0.00586	CbGeAlD
Ruxolitinib—TAOK3—trachea—allergic rhinitis	0.00193	0.00581	CbGeAlD
Ruxolitinib—Skin disorder—Olopatadine—allergic rhinitis	0.00193	0.00772	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Diphenhydramine—allergic rhinitis	0.00191	0.00762	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Dimenhydrinate—allergic rhinitis	0.00191	0.00762	CcSEcCtD
Ruxolitinib—Infestation NOS—Montelukast—allergic rhinitis	0.00186	0.00741	CcSEcCtD
Ruxolitinib—Infestation—Montelukast—allergic rhinitis	0.00186	0.00741	CcSEcCtD
Ruxolitinib—Body temperature increased—Desloratadine—allergic rhinitis	0.00184	0.00735	CcSEcCtD
Ruxolitinib—MAP3K2—lung—allergic rhinitis	0.00179	0.00537	CbGeAlD
Ruxolitinib—CYP3A4—Dexamethasone—allergic rhinitis	0.00178	0.0381	CbGbCtD
Ruxolitinib—MAP3K7—lung—allergic rhinitis	0.00177	0.00532	CbGeAlD
Ruxolitinib—Hepatobiliary disease—Montelukast—allergic rhinitis	0.00176	0.00701	CcSEcCtD
Ruxolitinib—Contusion—Dexamethasone—allergic rhinitis	0.00175	0.00701	CcSEcCtD
Ruxolitinib—Contusion—Betamethasone—allergic rhinitis	0.00175	0.00701	CcSEcCtD
Ruxolitinib—Epistaxis—Montelukast—allergic rhinitis	0.00175	0.00699	CcSEcCtD
Ruxolitinib—TYK2—lung—allergic rhinitis	0.00174	0.00522	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Olopatadine—allergic rhinitis	0.00172	0.00687	CcSEcCtD
Ruxolitinib—Asthenia—Cyproheptadine—allergic rhinitis	0.00172	0.00687	CcSEcCtD
Ruxolitinib—MKNK2—lung—allergic rhinitis	0.00172	0.00515	CbGeAlD
Ruxolitinib—IRAK1—lung—allergic rhinitis	0.00172	0.00515	CbGeAlD
Ruxolitinib—Fatigue—Olopatadine—allergic rhinitis	0.00172	0.00686	CcSEcCtD
Ruxolitinib—Flatulence—Cetirizine—allergic rhinitis	0.0017	0.00681	CcSEcCtD
Ruxolitinib—Malnutrition—Flunisolide—allergic rhinitis	0.0017	0.00679	CcSEcCtD
Ruxolitinib—Fatigue—Dimenhydrinate—allergic rhinitis	0.00168	0.00671	CcSEcCtD
Ruxolitinib—Fatigue—Diphenhydramine—allergic rhinitis	0.00168	0.00671	CcSEcCtD
Ruxolitinib—Asthenia—Desloratadine—allergic rhinitis	0.00167	0.00667	CcSEcCtD
Ruxolitinib—Pruritus—Desloratadine—allergic rhinitis	0.00165	0.00658	CcSEcCtD
Ruxolitinib—Dizziness—Cyproheptadine—allergic rhinitis	0.00158	0.00633	CcSEcCtD
Ruxolitinib—JAK2—lung—allergic rhinitis	0.00158	0.00475	CbGeAlD
Ruxolitinib—Body temperature increased—Olopatadine—allergic rhinitis	0.00157	0.00629	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Loratadine—allergic rhinitis	0.00155	0.00621	CcSEcCtD
Ruxolitinib—Dizziness—Desloratadine—allergic rhinitis	0.00154	0.00615	CcSEcCtD
Ruxolitinib—MAP3K3—lung—allergic rhinitis	0.00152	0.00458	CbGeAlD
Ruxolitinib—Headache—Cyproheptadine—allergic rhinitis	0.0015	0.00599	CcSEcCtD
Ruxolitinib—Nervous system disorder—Loratadine—allergic rhinitis	0.00147	0.00588	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Cetirizine—allergic rhinitis	0.00146	0.00584	CcSEcCtD
Ruxolitinib—Headache—Desloratadine—allergic rhinitis	0.00146	0.00583	CcSEcCtD
Ruxolitinib—Skin disorder—Loratadine—allergic rhinitis	0.00146	0.00582	CcSEcCtD
Ruxolitinib—Asthenia—Olopatadine—allergic rhinitis	0.00143	0.00571	CcSEcCtD
Ruxolitinib—Pruritus—Olopatadine—allergic rhinitis	0.00141	0.00563	CcSEcCtD
Ruxolitinib—Infection—Cetirizine—allergic rhinitis	0.0014	0.0056	CcSEcCtD
Ruxolitinib—Asthenia—Dimenhydrinate—allergic rhinitis	0.0014	0.00558	CcSEcCtD
Ruxolitinib—Asthenia—Diphenhydramine—allergic rhinitis	0.0014	0.00558	CcSEcCtD
Ruxolitinib—TAOK3—lung—allergic rhinitis	0.00139	0.00417	CbGeAlD
Ruxolitinib—Nervous system disorder—Cetirizine—allergic rhinitis	0.00138	0.00553	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Cetirizine—allergic rhinitis	0.00138	0.00552	CcSEcCtD
Ruxolitinib—Infection—Flunisolide—allergic rhinitis	0.00138	0.00551	CcSEcCtD
Ruxolitinib—Skin disorder—Cetirizine—allergic rhinitis	0.00137	0.00548	CcSEcCtD
Ruxolitinib—Dizziness—Olopatadine—allergic rhinitis	0.00132	0.00526	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Loratadine—allergic rhinitis	0.0013	0.00517	CcSEcCtD
Ruxolitinib—Fatigue—Loratadine—allergic rhinitis	0.00129	0.00517	CcSEcCtD
Ruxolitinib—Dizziness—Dimenhydrinate—allergic rhinitis	0.00129	0.00515	CcSEcCtD
Ruxolitinib—Dizziness—Diphenhydramine—allergic rhinitis	0.00129	0.00515	CcSEcCtD
Ruxolitinib—Headache—Olopatadine—allergic rhinitis	0.00125	0.00498	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Montelukast—allergic rhinitis	0.00123	0.0049	CcSEcCtD
Ruxolitinib—Headache—Diphenhydramine—allergic rhinitis	0.00122	0.00488	CcSEcCtD
Ruxolitinib—Headache—Dimenhydrinate—allergic rhinitis	0.00122	0.00488	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.00122	0.00487	CcSEcCtD
Ruxolitinib—Fatigue—Cetirizine—allergic rhinitis	0.00122	0.00486	CcSEcCtD
Ruxolitinib—Fatigue—Flunisolide—allergic rhinitis	0.0012	0.00478	CcSEcCtD
Ruxolitinib—Body temperature increased—Loratadine—allergic rhinitis	0.00119	0.00474	CcSEcCtD
Ruxolitinib—Infection—Montelukast—allergic rhinitis	0.00118	0.0047	CcSEcCtD
Ruxolitinib—Nervous system disorder—Montelukast—allergic rhinitis	0.00116	0.00464	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Montelukast—allergic rhinitis	0.00116	0.00463	CcSEcCtD
Ruxolitinib—Skin disorder—Montelukast—allergic rhinitis	0.00115	0.00459	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Hydrocortisone—allergic rhinitis	0.00115	0.00458	CcSEcCtD
Ruxolitinib—Body temperature increased—Cetirizine—allergic rhinitis	0.00112	0.00446	CcSEcCtD
Ruxolitinib—Body temperature increased—Flunisolide—allergic rhinitis	0.0011	0.00438	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Methylprednisolone—allergic rhinitis	0.00108	0.00431	CcSEcCtD
Ruxolitinib—Asthenia—Loratadine—allergic rhinitis	0.00108	0.0043	CcSEcCtD
Ruxolitinib—Weight increased—Prednisolone—allergic rhinitis	0.00105	0.00418	CcSEcCtD
Ruxolitinib—Weight increased—Hydrocortisone—allergic rhinitis	0.00102	0.00409	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.00102	0.00408	CcSEcCtD
Ruxolitinib—Fatigue—Montelukast—allergic rhinitis	0.00102	0.00408	CcSEcCtD
Ruxolitinib—Weight decreased—Hydrocortisone—allergic rhinitis	0.00102	0.00406	CcSEcCtD
Ruxolitinib—Asthenia—Cetirizine—allergic rhinitis	0.00101	0.00405	CcSEcCtD
Ruxolitinib—Infestation NOS—Hydrocortisone—allergic rhinitis	0.001	0.004	CcSEcCtD
Ruxolitinib—Infestation—Hydrocortisone—allergic rhinitis	0.001	0.004	CcSEcCtD
Ruxolitinib—Pruritus—Cetirizine—allergic rhinitis	0.000999	0.00399	CcSEcCtD
Ruxolitinib—Asthenia—Flunisolide—allergic rhinitis	0.000996	0.00398	CcSEcCtD
Ruxolitinib—Dizziness—Loratadine—allergic rhinitis	0.000992	0.00396	CcSEcCtD
Ruxolitinib—Pruritus—Flunisolide—allergic rhinitis	0.000982	0.00392	CcSEcCtD
Ruxolitinib—Weight increased—Triamcinolone—allergic rhinitis	0.000963	0.00385	CcSEcCtD
Ruxolitinib—Weight increased—Methylprednisolone—allergic rhinitis	0.000961	0.00384	CcSEcCtD
Ruxolitinib—Infestation—Methylprednisolone—allergic rhinitis	0.000942	0.00376	CcSEcCtD
Ruxolitinib—Infestation NOS—Methylprednisolone—allergic rhinitis	0.000942	0.00376	CcSEcCtD
Ruxolitinib—Headache—Loratadine—allergic rhinitis	0.00094	0.00375	CcSEcCtD
Ruxolitinib—Body temperature increased—Montelukast—allergic rhinitis	0.000936	0.00374	CcSEcCtD
Ruxolitinib—Dizziness—Cetirizine—allergic rhinitis	0.000933	0.00373	CcSEcCtD
Ruxolitinib—Haemoglobin—Prednisolone—allergic rhinitis	0.000926	0.0037	CcSEcCtD
Ruxolitinib—Haemorrhage—Prednisolone—allergic rhinitis	0.000921	0.00368	CcSEcCtD
Ruxolitinib—Dizziness—Flunisolide—allergic rhinitis	0.000918	0.00367	CcSEcCtD
Ruxolitinib—Haemoglobin—Hydrocortisone—allergic rhinitis	0.000904	0.00361	CcSEcCtD
Ruxolitinib—Haemorrhage—Hydrocortisone—allergic rhinitis	0.0009	0.00359	CcSEcCtD
Ruxolitinib—Epistaxis—Triamcinolone—allergic rhinitis	0.00089	0.00356	CcSEcCtD
Ruxolitinib—Headache—Cetirizine—allergic rhinitis	0.000884	0.00353	CcSEcCtD
Ruxolitinib—Weight increased—Betamethasone—allergic rhinitis	0.000874	0.00349	CcSEcCtD
Ruxolitinib—Weight increased—Dexamethasone—allergic rhinitis	0.000874	0.00349	CcSEcCtD
Ruxolitinib—Headache—Flunisolide—allergic rhinitis	0.000869	0.00347	CcSEcCtD
Ruxolitinib—Weight decreased—Dexamethasone—allergic rhinitis	0.000869	0.00347	CcSEcCtD
Ruxolitinib—Weight decreased—Betamethasone—allergic rhinitis	0.000869	0.00347	CcSEcCtD
Ruxolitinib—Haemoglobin—Triamcinolone—allergic rhinitis	0.000851	0.0034	CcSEcCtD
Ruxolitinib—Haemoglobin—Methylprednisolone—allergic rhinitis	0.00085	0.00339	CcSEcCtD
Ruxolitinib—Asthenia—Montelukast—allergic rhinitis	0.000849	0.00339	CcSEcCtD
Ruxolitinib—Haemorrhage—Triamcinolone—allergic rhinitis	0.000847	0.00338	CcSEcCtD
Ruxolitinib—Haemorrhage—Methylprednisolone—allergic rhinitis	0.000845	0.00338	CcSEcCtD
Ruxolitinib—Pruritus—Montelukast—allergic rhinitis	0.000837	0.00335	CcSEcCtD
Ruxolitinib—Malnutrition—Hydrocortisone—allergic rhinitis	0.000783	0.00313	CcSEcCtD
Ruxolitinib—Dizziness—Montelukast—allergic rhinitis	0.000783	0.00313	CcSEcCtD
Ruxolitinib—Haemoglobin—Dexamethasone—allergic rhinitis	0.000773	0.00309	CcSEcCtD
Ruxolitinib—Haemoglobin—Betamethasone—allergic rhinitis	0.000773	0.00309	CcSEcCtD
Ruxolitinib—Haemorrhage—Betamethasone—allergic rhinitis	0.000769	0.00307	CcSEcCtD
Ruxolitinib—Haemorrhage—Dexamethasone—allergic rhinitis	0.000769	0.00307	CcSEcCtD
Ruxolitinib—Headache—Montelukast—allergic rhinitis	0.000741	0.00296	CcSEcCtD
Ruxolitinib—Malnutrition—Methylprednisolone—allergic rhinitis	0.000736	0.00294	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000662	0.00265	CcSEcCtD
Ruxolitinib—Infection—Hydrocortisone—allergic rhinitis	0.000635	0.00254	CcSEcCtD
Ruxolitinib—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000627	0.0025	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000622	0.00249	CcSEcCtD
Ruxolitinib—Skin disorder—Hydrocortisone—allergic rhinitis	0.000621	0.00248	CcSEcCtD
Ruxolitinib—Infection—Triamcinolone—allergic rhinitis	0.000598	0.00239	CcSEcCtD
Ruxolitinib—Infection—Methylprednisolone—allergic rhinitis	0.000597	0.00238	CcSEcCtD
Ruxolitinib—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000589	0.00235	CcSEcCtD
Ruxolitinib—Skin disorder—Methylprednisolone—allergic rhinitis	0.000583	0.00233	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000552	0.0022	CcSEcCtD
Ruxolitinib—Fatigue—Hydrocortisone—allergic rhinitis	0.000551	0.0022	CcSEcCtD
Ruxolitinib—Infection—Dexamethasone—allergic rhinitis	0.000543	0.00217	CcSEcCtD
Ruxolitinib—Infection—Betamethasone—allergic rhinitis	0.000543	0.00217	CcSEcCtD
Ruxolitinib—Nervous system disorder—Betamethasone—allergic rhinitis	0.000536	0.00214	CcSEcCtD
Ruxolitinib—Nervous system disorder—Dexamethasone—allergic rhinitis	0.000536	0.00214	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Betamethasone—allergic rhinitis	0.000535	0.00214	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Dexamethasone—allergic rhinitis	0.000535	0.00214	CcSEcCtD
Ruxolitinib—Fatigue—Triamcinolone—allergic rhinitis	0.000519	0.00207	CcSEcCtD
Ruxolitinib—Fatigue—Methylprednisolone—allergic rhinitis	0.000518	0.00207	CcSEcCtD
Ruxolitinib—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000505	0.00202	CcSEcCtD
Ruxolitinib—Body temperature increased—Triamcinolone—allergic rhinitis	0.000476	0.0019	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000471	0.00188	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000471	0.00188	CcSEcCtD
Ruxolitinib—Fatigue—Dexamethasone—allergic rhinitis	0.000471	0.00188	CcSEcCtD
Ruxolitinib—Fatigue—Betamethasone—allergic rhinitis	0.000471	0.00188	CcSEcCtD
Ruxolitinib—Asthenia—Hydrocortisone—allergic rhinitis	0.000459	0.00183	CcSEcCtD
Ruxolitinib—Pruritus—Hydrocortisone—allergic rhinitis	0.000452	0.00181	CcSEcCtD
Ruxolitinib—Dizziness—Prednisolone—allergic rhinitis	0.000433	0.00173	CcSEcCtD
Ruxolitinib—Asthenia—Triamcinolone—allergic rhinitis	0.000432	0.00173	CcSEcCtD
Ruxolitinib—Body temperature increased—Betamethasone—allergic rhinitis	0.000432	0.00172	CcSEcCtD
Ruxolitinib—Body temperature increased—Dexamethasone—allergic rhinitis	0.000432	0.00172	CcSEcCtD
Ruxolitinib—Asthenia—Methylprednisolone—allergic rhinitis	0.000431	0.00172	CcSEcCtD
Ruxolitinib—Pruritus—Triamcinolone—allergic rhinitis	0.000426	0.0017	CcSEcCtD
Ruxolitinib—Pruritus—Methylprednisolone—allergic rhinitis	0.000425	0.0017	CcSEcCtD
Ruxolitinib—Dizziness—Hydrocortisone—allergic rhinitis	0.000423	0.00169	CcSEcCtD
Ruxolitinib—Headache—Prednisolone—allergic rhinitis	0.00041	0.00164	CcSEcCtD
Ruxolitinib—Headache—Hydrocortisone—allergic rhinitis	0.0004	0.0016	CcSEcCtD
Ruxolitinib—Dizziness—Triamcinolone—allergic rhinitis	0.000398	0.00159	CcSEcCtD
Ruxolitinib—Dizziness—Methylprednisolone—allergic rhinitis	0.000397	0.00159	CcSEcCtD
Ruxolitinib—Asthenia—Dexamethasone—allergic rhinitis	0.000392	0.00157	CcSEcCtD
Ruxolitinib—Asthenia—Betamethasone—allergic rhinitis	0.000392	0.00157	CcSEcCtD
Ruxolitinib—Pruritus—Dexamethasone—allergic rhinitis	0.000386	0.00154	CcSEcCtD
Ruxolitinib—Pruritus—Betamethasone—allergic rhinitis	0.000386	0.00154	CcSEcCtD
Ruxolitinib—Headache—Triamcinolone—allergic rhinitis	0.000377	0.00151	CcSEcCtD
Ruxolitinib—Headache—Methylprednisolone—allergic rhinitis	0.000376	0.0015	CcSEcCtD
Ruxolitinib—Dizziness—Dexamethasone—allergic rhinitis	0.000361	0.00144	CcSEcCtD
Ruxolitinib—Dizziness—Betamethasone—allergic rhinitis	0.000361	0.00144	CcSEcCtD
Ruxolitinib—Headache—Dexamethasone—allergic rhinitis	0.000342	0.00137	CcSEcCtD
Ruxolitinib—Headache—Betamethasone—allergic rhinitis	0.000342	0.00137	CcSEcCtD
Ruxolitinib—JAK2—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	0.000199	0.000547	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by NGF—NFKB1—allergic rhinitis	0.000198	0.000543	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TAC1—allergic rhinitis	0.000197	0.00054	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—PTGDR2—allergic rhinitis	0.000196	0.000538	CbGpPWpGaD
Ruxolitinib—JAK2—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.000196	0.000538	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—HLA-G—allergic rhinitis	0.000196	0.000536	CbGpPWpGaD
Ruxolitinib—IRAK1—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	0.000195	0.000534	CbGpPWpGaD
Ruxolitinib—JAK2—Interferon Signaling—ICAM1—allergic rhinitis	0.000194	0.000531	CbGpPWpGaD
Ruxolitinib—CAMK2G—Cellular responses to stress—NFKB1—allergic rhinitis	0.000194	0.000531	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—HLA-G—allergic rhinitis	0.000193	0.000528	CbGpPWpGaD
Ruxolitinib—IRAK1—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	0.000193	0.000528	CbGpPWpGaD
Ruxolitinib—PRKG2—Hemostasis—TGFB1—allergic rhinitis	0.000189	0.000519	CbGpPWpGaD
Ruxolitinib—JAK2—MyD88-independent cascade—NFKB1—allergic rhinitis	0.000188	0.000516	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—IL5—allergic rhinitis	0.000187	0.000513	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Developmental Biology—TGFB1—allergic rhinitis	0.000187	0.000513	CbGpPWpGaD
Ruxolitinib—TYK2—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	0.000187	0.000513	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—ADIPOQ—allergic rhinitis	0.000186	0.000509	CbGpPWpGaD
Ruxolitinib—MAP3K7—DNA Damage Response (only ATM dependent)—TGFB1—allergic rhinitis	0.000186	0.000509	CbGpPWpGaD
Ruxolitinib—CAMK2G—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.000185	0.000506	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—SMAD3—allergic rhinitis	0.000184	0.000505	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL5—allergic rhinitis	0.000184	0.000505	CbGpPWpGaD
Ruxolitinib—MAP3K7—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	0.000183	0.000503	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IL5—allergic rhinitis	0.000183	0.000502	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—TAC1—allergic rhinitis	0.000183	0.000501	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—SMAD3—allergic rhinitis	0.000183	0.000501	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000182	0.0005	CbGpPWpGaD
Ruxolitinib—MAP3K7—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	0.000181	0.000497	CbGpPWpGaD
Ruxolitinib—MAP3K3—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.00018	0.000494	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—SMAD3—allergic rhinitis	0.00018	0.000493	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.000177	0.000486	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CCL11—allergic rhinitis	0.000176	0.000483	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000176	0.000482	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.000176	0.000482	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by Interleukins—NFKB1—allergic rhinitis	0.000175	0.000481	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—TAC1—allergic rhinitis	0.000173	0.000475	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—MS4A2—allergic rhinitis	0.000172	0.000471	CbGpPWpGaD
Ruxolitinib—JAK3—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	0.000171	0.000469	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.000171	0.000468	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—TAC1—allergic rhinitis	0.00017	0.000467	CbGpPWpGaD
Ruxolitinib—JAK3—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.00017	0.000466	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—IL5—allergic rhinitis	0.00017	0.000466	CbGpPWpGaD
Ruxolitinib—JAK2—Activated TLR4 signalling—NFKB1—allergic rhinitis	0.000169	0.000464	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—PTGDR2—allergic rhinitis	0.000169	0.000463	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL5—allergic rhinitis	0.000169	0.000462	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—PTGDR2—allergic rhinitis	0.000166	0.000455	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—HLA-G—allergic rhinitis	0.000166	0.000454	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.000166	0.000454	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000165	0.000454	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL5—allergic rhinitis	0.000165	0.000451	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—IL5—allergic rhinitis	0.000161	0.000441	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00016	0.000438	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CCL11—allergic rhinitis	0.00016	0.000438	CbGpPWpGaD
Ruxolitinib—MAP3K7—TGF-beta Signaling Pathway—TGFB1—allergic rhinitis	0.000159	0.000437	CbGpPWpGaD
Ruxolitinib—JAK2—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	0.000159	0.000436	CbGpPWpGaD
Ruxolitinib—MAP3K7—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000158	0.000434	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—IL5—allergic rhinitis	0.000158	0.000434	CbGpPWpGaD
Ruxolitinib—MAP3K7—MAPK Signaling Pathway—NFKB1—allergic rhinitis	0.000158	0.000432	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—TAC1—allergic rhinitis	0.000157	0.000431	CbGpPWpGaD
Ruxolitinib—TYK2—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	0.000156	0.000427	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL5—allergic rhinitis	0.000155	0.000426	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—TAC1—allergic rhinitis	0.000155	0.000424	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000154	0.000422	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—SMAD3—allergic rhinitis	0.000152	0.000416	CbGpPWpGaD
Ruxolitinib—MAP3K7—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	0.000151	0.000415	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CCL11—allergic rhinitis	0.000149	0.000408	CbGpPWpGaD
Ruxolitinib—JAK1—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	0.000147	0.000404	CbGpPWpGaD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.000146	0.000401	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—IL5—allergic rhinitis	0.000146	0.000401	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by NGF—NFKB1—allergic rhinitis	0.000144	0.000394	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—IL5—allergic rhinitis	0.000144	0.000394	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—SMAD3—allergic rhinitis	0.000143	0.000391	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—IL5—allergic rhinitis	0.000143	0.000391	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—HLA-DQB1—allergic rhinitis	0.000142	0.000391	CbGpPWpGaD
Ruxolitinib—JAK2—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	0.000142	0.000389	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—ADIPOQ—allergic rhinitis	0.000141	0.000386	CbGpPWpGaD
Ruxolitinib—MAP3K7—B Cell Activation—NFKB1—allergic rhinitis	0.00014	0.000384	CbGpPWpGaD
Ruxolitinib—JAK2—BDNF signaling pathway—NFKB1—allergic rhinitis	0.000139	0.000382	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000138	0.000379	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—SMAD3—allergic rhinitis	0.000135	0.00037	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL5—allergic rhinitis	0.000134	0.000366	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000132	0.000363	CbGpPWpGaD
Ruxolitinib—MAP3K7—MAPK Signaling Pathway—TGFB1—allergic rhinitis	0.000131	0.00036	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—CD4—allergic rhinitis	0.000131	0.00036	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—HLA-DQB1—allergic rhinitis	0.000131	0.000358	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CYSLTR1—allergic rhinitis	0.00013	0.000357	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.000129	0.000355	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—SMAD3—allergic rhinitis	0.000129	0.000354	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PTGDR2—allergic rhinitis	0.000128	0.000352	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TAC1—allergic rhinitis	0.000128	0.000351	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CCL11—allergic rhinitis	0.000128	0.000351	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—HLA-DQB1—allergic rhinitis	0.000127	0.000349	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—HLA-G—allergic rhinitis	0.000126	0.000346	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CCL11—allergic rhinitis	0.000126	0.000345	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000125	0.000344	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PTGDR2—allergic rhinitis	0.000125	0.000342	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—HLA-G—allergic rhinitis	0.000122	0.000335	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000122	0.000335	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CCL11—allergic rhinitis	0.000121	0.000332	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PTGDR2—allergic rhinitis	0.000121	0.000331	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—HLA-DQB1—allergic rhinitis	0.00012	0.00033	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—CD4—allergic rhinitis	0.00012	0.000329	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—SMAD3—allergic rhinitis	0.00012	0.000328	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL5—allergic rhinitis	0.000119	0.000326	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—HLA-G—allergic rhinitis	0.000119	0.000325	CbGpPWpGaD
Ruxolitinib—JAK2—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	0.000118	0.000324	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—TAC1—allergic rhinitis	0.000116	0.000318	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—NFKB1—allergic rhinitis	0.000113	0.00031	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.000111	0.000305	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—NFKB1—allergic rhinitis	0.000109	0.0003	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—CD4—allergic rhinitis	0.000109	0.000298	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.000108	0.000296	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TAC1—allergic rhinitis	0.000108	0.000296	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL5—allergic rhinitis	0.000108	0.000296	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—NFKB1—allergic rhinitis	0.000106	0.000291	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.000105	0.000287	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—TGFB1—allergic rhinitis	0.000105	0.000287	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—ICAM1—allergic rhinitis	0.000104	0.000285	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—HLA-DQB1—allergic rhinitis	0.000103	0.000284	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—SMAD3—allergic rhinitis	0.000102	0.00028	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL5—allergic rhinitis	0.000102	0.000279	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000101	0.000276	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL5—allergic rhinitis	0.0001	0.000275	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL5—allergic rhinitis	9.86e-05	0.00027	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CYSLTR1—allergic rhinitis	9.78e-05	0.000268	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CCL11—allergic rhinitis	9.72e-05	0.000267	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—TAC1—allergic rhinitis	9.69e-05	0.000266	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL5—allergic rhinitis	9.57e-05	0.000262	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—CD4—allergic rhinitis	9.53e-05	0.000261	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—ICAM1—allergic rhinitis	9.52e-05	0.000261	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CYSLTR1—allergic rhinitis	9.48e-05	0.00026	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PTGDR2—allergic rhinitis	9.44e-05	0.000259	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCL11—allergic rhinitis	9.44e-05	0.000259	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—ICAM1—allergic rhinitis	9.3e-05	0.000255	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—NFKB1—allergic rhinitis	9.29e-05	0.000255	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TAC1—allergic rhinitis	9.29e-05	0.000255	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HLA-G—allergic rhinitis	9.27e-05	0.000254	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCL11—allergic rhinitis	9.16e-05	0.000251	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—NFKB1—allergic rhinitis	9.14e-05	0.000251	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TAC1—allergic rhinitis	9.14e-05	0.000251	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—IL5—allergic rhinitis	9.01e-05	0.000247	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—ICAM1—allergic rhinitis	8.91e-05	0.000244	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—TGFB1—allergic rhinitis	8.83e-05	0.000242	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—TAC1—allergic rhinitis	8.8e-05	0.000241	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—ICAM1—allergic rhinitis	8.78e-05	0.000241	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—SMAD3—allergic rhinitis	8.68e-05	0.000238	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL5—allergic rhinitis	8.64e-05	0.000237	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—TGFB1—allergic rhinitis	8.62e-05	0.000236	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL5—allergic rhinitis	8.5e-05	0.000233	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—SMAD3—allergic rhinitis	8.37e-05	0.00023	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	8.24e-05	0.000226	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—NFKB1—allergic rhinitis	8.21e-05	0.000225	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	8.19e-05	0.000224	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL5—allergic rhinitis	8.18e-05	0.000224	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—NFKB1—allergic rhinitis	8.05e-05	0.000221	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—HLA-DQB1—allergic rhinitis	7.87e-05	0.000216	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—TGFB1—allergic rhinitis	7.8e-05	0.000214	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—TGFB1—allergic rhinitis	7.74e-05	0.000212	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—NFKB1—allergic rhinitis	7.71e-05	0.000211	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CD4—allergic rhinitis	7.64e-05	0.00021	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—HLA-DQB1—allergic rhinitis	7.64e-05	0.000209	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—TGFB1—allergic rhinitis	7.61e-05	0.000209	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—TGFB1—allergic rhinitis	7.59e-05	0.000208	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—ICAM1—allergic rhinitis	7.55e-05	0.000207	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL5—allergic rhinitis	7.48e-05	0.000205	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CYSLTR1—allergic rhinitis	7.41e-05	0.000203	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—HLA-DQB1—allergic rhinitis	7.41e-05	0.000203	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—NFKB1—allergic rhinitis	7.25e-05	0.000199	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—CD4—allergic rhinitis	7.24e-05	0.000199	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCL11—allergic rhinitis	7.15e-05	0.000196	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—SMAD3—allergic rhinitis	7.07e-05	0.000194	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TAC1—allergic rhinitis	7.07e-05	0.000194	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—CD4—allergic rhinitis	7.06e-05	0.000193	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—CD4—allergic rhinitis	7.03e-05	0.000193	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CD4—allergic rhinitis	7e-05	0.000192	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—NFKB1—allergic rhinitis	6.86e-05	0.000188	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TAC1—allergic rhinitis	6.86e-05	0.000188	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CD4—allergic rhinitis	6.84e-05	0.000187	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—CD4—allergic rhinitis	6.82e-05	0.000187	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TAC1—allergic rhinitis	6.65e-05	0.000182	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—NFKB1—allergic rhinitis	6.58e-05	0.00018	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL5—allergic rhinitis	6.57e-05	0.00018	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—NFKB1—allergic rhinitis	6.56e-05	0.00018	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CD4—allergic rhinitis	6.55e-05	0.00018	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CD4—allergic rhinitis	6.45e-05	0.000177	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—TGFB1—allergic rhinitis	6.42e-05	0.000176	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—SMAD3—allergic rhinitis	6.41e-05	0.000176	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL5—allergic rhinitis	6.38e-05	0.000175	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—NFKB1—allergic rhinitis	6.24e-05	0.000171	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL5—allergic rhinitis	6.19e-05	0.00017	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—SMAD3—allergic rhinitis	6.08e-05	0.000167	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—NFKB1—allergic rhinitis	6.06e-05	0.000166	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—TGFB1—allergic rhinitis	6.04e-05	0.000166	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—NFKB1—allergic rhinitis	6.03e-05	0.000165	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—SMAD3—allergic rhinitis	5.98e-05	0.000164	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—NFKB1—allergic rhinitis	5.89e-05	0.000161	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—NFKB1—allergic rhinitis	5.88e-05	0.000161	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HLA-DQB1—allergic rhinitis	5.79e-05	0.000159	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—ICAM1—allergic rhinitis	5.74e-05	0.000157	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—TGFB1—allergic rhinitis	5.71e-05	0.000157	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—NFKB1—allergic rhinitis	5.64e-05	0.000155	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—ICAM1—allergic rhinitis	5.57e-05	0.000153	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—NFKB1—allergic rhinitis	5.56e-05	0.000152	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CD4—allergic rhinitis	5.55e-05	0.000152	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TGFB1—allergic rhinitis	5.46e-05	0.00015	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—ICAM1—allergic rhinitis	5.41e-05	0.000148	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CD4—allergic rhinitis	5.33e-05	0.000146	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—NFKB1—allergic rhinitis	5.2e-05	0.000143	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TAC1—allergic rhinitis	5.2e-05	0.000143	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CD4—allergic rhinitis	5.12e-05	0.00014	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—TGFB1—allergic rhinitis	5.06e-05	0.000139	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—SMAD3—allergic rhinitis	4.86e-05	0.000133	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL5—allergic rhinitis	4.83e-05	0.000133	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—NFKB1—allergic rhinitis	4.78e-05	0.000131	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—SMAD3—allergic rhinitis	4.62e-05	0.000127	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—NFKB1—allergic rhinitis	4.59e-05	0.000126	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—SMAD3—allergic rhinitis	4.49e-05	0.000123	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—SMAD3—allergic rhinitis	4.35e-05	0.000119	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TGFB1—allergic rhinitis	4.33e-05	0.000119	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NFKB1—allergic rhinitis	4.26e-05	0.000117	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—TGFB1—allergic rhinitis	4.25e-05	0.000116	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—ICAM1—allergic rhinitis	4.22e-05	0.000116	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD4—allergic rhinitis	4.22e-05	0.000116	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD4—allergic rhinitis	4.1e-05	0.000112	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD4—allergic rhinitis	3.97e-05	0.000109	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CD4—allergic rhinitis	3.78e-05	0.000104	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—TGFB1—allergic rhinitis	3.68e-05	0.000101	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—NFKB1—allergic rhinitis	3.63e-05	9.97e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NFKB1—allergic rhinitis	3.59e-05	9.85e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TGFB1—allergic rhinitis	3.55e-05	9.72e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—NFKB1—allergic rhinitis	3.53e-05	9.67e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—NFKB1—allergic rhinitis	3.42e-05	9.38e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SMAD3—allergic rhinitis	3.4e-05	9.33e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD4—allergic rhinitis	3.1e-05	8.51e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NFKB1—allergic rhinitis	3.09e-05	8.47e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NFKB1—allergic rhinitis	3.04e-05	8.33e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TGFB1—allergic rhinitis	2.99e-05	8.2e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CD4—allergic rhinitis	2.87e-05	7.86e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—TGFB1—allergic rhinitis	2.71e-05	7.44e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—NFKB1—allergic rhinitis	2.67e-05	7.33e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TGFB1—allergic rhinitis	2.57e-05	7.06e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TGFB1—allergic rhinitis	2.53e-05	6.94e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NFKB1—allergic rhinitis	2.35e-05	6.44e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NFKB1—allergic rhinitis	2.28e-05	6.25e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NFKB1—allergic rhinitis	2.21e-05	6.07e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TGFB1—allergic rhinitis	2.06e-05	5.64e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TGFB1—allergic rhinitis	1.96e-05	5.37e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TGFB1—allergic rhinitis	1.9e-05	5.21e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TGFB1—allergic rhinitis	1.84e-05	5.05e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NFKB1—allergic rhinitis	1.73e-05	4.74e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TGFB1—allergic rhinitis	1.44e-05	3.95e-05	CbGpPWpGaD
